March 24, 2020

COVID-19: a message of solidarity on World TB Day 2020

March 4, 2020

Nix-TB Trial Results Published in New England Journal of Medicine

February 12, 2020

TB Alliance Names Dr. Daniel Everitt Vice President and Chief Medical Officer

Dr. Everitt to lead development planning of novel drug regimens to treat tuberculosis

February 3, 2020

Jane Griffiths Joins TB Alliance Board of Directors

Griffiths has 35 years of experience in the healthcare industry

January 30, 2020

TB Research Funding Continues to Fall Short

Statement on 2019 G-FINDER Report

January 29, 2020

TB Alliance Partners with ERA4TB, an International Consortium to Accelerate the Development of Comprehensive Treatments against Tuberculosis

More than 30 partners from 13 countries participate in the ERA4TB project

January 27, 2020

New Research Assesses Efficacy of Different Doses of Linezolid, Key Medicine Used in Regimens that Treat Drug-Resistant Tuberculosis

January 16, 2020

TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant Forms of TB in China

Non-profit drug developer partners with leading manufacturer of tuberculosis medicine in China

November 13, 2019

Results of Phase 2B Clinical Trial Testing New Drug-Resistant TB Treatment Published in Lancet Respiratory Medicine

November 6, 2019

Global Health Innovators Come Together to Identify Ways to Further Strengthen European Investment in Global Health Research & Innovation